Log in to your Inderes Free account to see all free content on this page.
FluoGuide
42.50 SEK
-1.62 %
Less than 1K followers
FLUO
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.62 %
-2.52 %
+22.13 %
+23.91 %
-0.70 %
+11.84 %
-48.92 %
-61.36 %
+374.05 %
FluoGuide is a Danish company operating in the medical technology sector. The company's business focus is on research and development of treatments for various forms of cancer, with the greatest focus on the development of products that guide surgical procedures. The products bind to cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Read moreMarket cap
694.85M SEK
Turnover
235.63K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.5.
2026
Interim report Q1'26
25.8.
2026
Interim report Q2'26
26.11.
2026
Interim report Q3'26
All
Research
Webcasts
Press releases
ShowingAll content types
Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, re-presented at SNOG
Redeye: FluoGuide: Shining light on a mispriced opportunity
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio